HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention.

AbstractBACKGROUND:
Accurate estimation of bleeding risk in patients undergoing elective percutaneous coronary intervention (PCI) is difficult and not based on widely accepted scores or characteristics. We developed and validated a simple prediction model for major bleeding using the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial, which demonstrated the superior safety of enoxaparin over unfractionated heparin (UFH) in 3528 patients undergoing elective PCI.
METHODS AND RESULTS:
Independent predictors of non-coronary artery bypass graft (CABG)-related major bleeding events were determined using stepwise multivariate logistic regression analysis from a development dataset using bootstrap resampling. These predictors were assigned an integer coefficient (risk score) proportional to the estimated coefficient from the logistic model. Risk scores were tested in a validation cohort. Female sex, use of unfractionated heparin (vs. enoxaparin), and use of a glycoprotein IIb/IIIa inhibitor (vs. nonuse) were the strongest independent predictors of bleeding. Extensive testing found that the final model performed well with bootstrap resampling in the development set (c-statistic 0.75; 95% CI: 0.70-0.82; Hosmer-Lemeshow p = 0.29), validation set (c-statistic 0.67; Hosmer-Lemeshow p = 0.12), and subgroups of high-risk patients analysed from the validation set (c-statistic ≥ 0.67).
CONCLUSIONS:
Our model for evaluating the risk of non-CABG-related major bleeding in patients undergoing elective PCI identified sex, the type of antithrombin used, and glycoprotein IIb/IIIa inhibitor use as important indicators of bleeding risk, and accurately predicted the incidence of non-CABG-related major bleeding in patients undergoing elective PCI in the STEEPLE trial.
AuthorsGilles Montalescot, Genevieve Salette, Gabriel Steg, Marc Cohen, Harvey D White, Richard Gallo, Steven R Steinhubl
JournalInternational journal of cardiology (Int J Cardiol) Vol. 150 Issue 1 Pg. 79-83 (Jul 01 2011) ISSN: 1874-1754 [Electronic] Netherlands
PMID20299114 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Validation Study)
CopyrightCopyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary (adverse effects)
  • Cohort Studies
  • Elective Surgical Procedures (adverse effects)
  • Female
  • Hemorrhage (diagnosis, epidemiology, etiology)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Hemorrhage (diagnosis, epidemiology, etiology)
  • Prospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: